Redwood City, CA, United States of America

Jianping Sun

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Baymedica, Inc.. Active years: 2020-2026.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Jianping Sun

Introduction

Jianping Sun is an accomplished inventor based in Redwood City, CA. She has made significant contributions to the field of biotechnology, particularly in the production of clinically important compounds. With a total of 4 patents, her work focuses on innovative methods for biosynthesis.

Latest Patents

Jianping Sun's latest patents include advancements in recombinant production systems for prenylated polyketides of the cannabinoid family. These inventions relate to production methods, enzymes, and recombinant yeast strains that facilitate the biosynthesis of these important compounds. By utilizing readily available starting materials, her work employs heterologous enzymes to direct cannabinoid biosynthesis in yeast.

Career Highlights

Throughout her career, Jianping has demonstrated a commitment to advancing biotechnological methods. Her innovative approaches have garnered attention in the scientific community, showcasing her expertise in the field.

Collaborations

Jianping has collaborated with notable professionals such as Philip J Barr and Charles K Marlowe, contributing to a dynamic work environment at Baymedica, Inc. These collaborations have further enhanced her research and development efforts.

Conclusion

Jianping Sun's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her innovative work continues to pave the way for advancements in cannabinoid biosynthesis.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…